CervoMed Statistics

Total Valuation

CervoMed has a market cap or net worth of $80.41 million. The enterprise value is $53.11 million.

Market Cap	80.41M
Enterprise Value	53.11M

Important Dates

The last earnings date was Monday, November 10, 2025, before market open.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

CervoMed has 9.25 million shares outstanding. The number of shares has increased by 19.31% in one year.

Current Share Class	9.25M
Shares Outstanding	9.25M
Shares Change (YoY)	+19.31%
Shares Change (QoQ)	+3.38%
Owned by Insiders (%)	32.06%
Owned by Institutions (%)	14.07%
Float	5.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.56
Forward PS	36.93
PB Ratio	3.09
P/TBV Ratio	3.09
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.62
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.66

Current Ratio	6.66
Quick Ratio	6.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -71.42% and return on invested capital (ROIC) is -47.46%.

Return on Equity (ROE)	-71.42%
Return on Assets (ROA)	-42.78%
Return on Invested Capital (ROIC)	-47.46%
Return on Capital Employed (ROCE)	-104.59%
Revenue Per Employee	$410,652
Profits Per Employee	-$1.71M
Employee Count	15
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.41% in the last 52 weeks. The beta is -6.48, so CervoMed's price volatility has been lower than the market average.

Beta (5Y)	-6.48
52-Week Price Change	-10.41%
50-Day Moving Average	7.98
200-Day Moving Average	8.03
Relative Strength Index (RSI)	53.10
Average Volume (20 Days)	86,573

Short Selling Information

The latest short interest is 110,625, so 1.20% of the outstanding shares have been sold short.

Short Interest	110,625
Short Previous Month	163,944
Short % of Shares Out	1.20%
Short % of Float	2.04%
Short Ratio (days to cover)	1.62

Income Statement

In the last 12 months, CervoMed had revenue of $6.16 million and -$25.58 million in losses. Loss per share was -$2.87.

Revenue	6.16M
Gross Profit	-16.91M
Operating Income	-27.20M
Pretax Income	-25.58M
Net Income	-25.58M
EBITDA	n/a
EBIT	-27.20M
Loss Per Share	-$2.87

Full Income Statement

Balance Sheet

The company has $27.29 million in cash and n/a in debt, giving a net cash position of $27.29 million or $2.95 per share.

Cash & Cash Equivalents	27.29M
Total Debt	n/a
Net Cash	27.29M
Net Cash Per Share	$2.95
Equity (Book Value)	26.01M
Book Value Per Share	2.81
Working Capital	26.01M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-24.93M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-274.58%
Operating Margin	-441.64%
Pretax Margin	-415.36%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CervoMed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.31%
Shareholder Yield	-19.31%
Earnings Yield	-31.82%
FCF Yield	n/a

Analyst Forecast

The average price target for CervoMed is $21.50, which is 147.41% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.50
Price Target Difference	147.41%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	59.95%
EPS Growth Forecast (5Y)	-1.88%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CervoMed has an Altman Z-Score of 2.87 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.87
Piotroski F-Score	1